Met Life Investment Management, LLC Abeona Therapeutics Inc. Transaction History
Met Life Investment Management, LLC
- $16.5 Billion
- Q2 2025
A detailed history of Met Life Investment Management, LLC transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 26,626 shares of ABEO stock, worth $145,644. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,626Holding current value
$145,644% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABEO
# of Institutions
104Shares Held
31.5MCall Options Held
2.42MPut Options Held
212K-
Nantahala Capital Management, LLC New Canaan, CT4.37MShares$23.9 Million1.08% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.07MShares$16.8 Million0.03% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.68MShares$14.6 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$13.7 Million0.0% of portfolio
-
Western Standard LLC Los Angeles, CA2.09MShares$11.4 Million6.61% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $32.5M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...